Status:
COMPLETED
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Lead Sponsor:
Medivation, Inc.
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
Eligibility Criteria
Inclusion
- Alzheimer's disease
- On Memantine
- Caregiver who is willing to accompany the patient to all clinic visits
Exclusion
- Unstable medical illnesses or significant hepatic or renal disease
- Other primary psychiatric or neurological disorders
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00829816
Start Date
December 1 2008
End Date
August 1 2010
Last Update
November 10 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Alamitos, California, United States, 90720
2
National City, California, United States, 91950
3
Delray Beach, Florida, United States, 33445
4
Orlando, Florida, United States, 32806